Physician
Bourtsos, Eleni
Bourtsos, Eleni was paid $2.28M by Medicaid between Jul 2019 and Dec 2024, across 140 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 13% of everything it billed.
33Billing provider infoBOURTSOS, ELENI
HINSDALE, IL 60521
HINSDALE, IL 60521
33aNPI1467453951assigned 08/09/2005
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.28M
24GClaims344,726
24DCodes billed140
24AFirst – last monthJul 2019 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#33 of 398
Median peer was paid$66K
This provider vs. median35×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 70 | $1K | |
| 2020 | 88 | $2K | |
| 2021 | 71,148 | $488K | |
| 2022 | 80,727 | $618K | |
| 2023 | 79,739 | $543K | |
| 2024incomplete | 112,954 | $631K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13% | 7,906 | 6,523 | $287K |
| 80053 | Comprehensive metabolic panel | 9.4% | 41,895 | 28,862 | $214K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 8.8% | 1,654 | 1,573 | $201K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.2% | 49,813 | 32,628 | $142K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.0% | 4,834 | 4,241 | $115K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 5.0% | 483 | 465 | $114K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.6% | 3,800 | 3,597 | $83K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.9% | 8,115 | 7,603 | $66K |
| 87040 | 2.3% | 4,600 | 3,708 | $53K | |
| 82947 | 2.3% | 10,035 | 4,056 | $53K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.2% | 12,350 | 7,440 | $50K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.2% | 1,397 | 1,227 | $49K |
128 more codes
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.1% | 1,496 | $49K |
| 84484 | 1.9% | 10,561 | $44K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.6% | 1,811 | $37K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.6% | 1,804 | $37K |
| 83880 | 1.6% | 3,037 | $36K | |
| 85027 | 1.3% | 10,155 | $29K | |
| 83735 | 1.2% | 8,465 | $28K | |
| 83690 | 1.2% | 8,182 | $27K | |
| 80061 | Lipid panel | 1.2% | 6,636 | $27K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.1% | 5,448 | $26K |
| 83605 | 1.1% | 4,683 | $25K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.0% | 2,533 | $24K |
| 81025 | <1% | 8,788 | $23K | |
| 85730 | <1% | 6,770 | $21K | |
| 81001 | <1% | 14,467 | $20K | |
| 82803 | <1% | 2,076 | $19K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,672 | $18K |
| 82805 | <1% | 611 | $17K | |
| 85610 | <1% | 8,867 | $17K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 531 | $16K |
| 86850 | <1% | 5,425 | $16K | |
| 85379 | <1% | 4,247 | $16K | |
| 87186 | <1% | 2,388 | $15K | |
| 86901 | <1% | 6,750 | $15K | |
| 82607 | <1% | 2,038 | $12K | |
| 86900 | <1% | 6,752 | $11K | |
| 84702 | <1% | 2,456 | $11K | |
| 87507 | <1% | 64 | $11K | |
| 87641 | <1% | 521 | $11K | |
| 80069 | <1% | 2,244 | $9K | |
| 82728 | <1% | 2,128 | $9K | |
| 84439 | <1% | 1,780 | $8K | |
| 83550 | <1% | 1,747 | $7K | |
| 84100 | <1% | 3,237 | $7K | |
| 86140 | <1% | 2,756 | $6K | |
| 82570 | <1% | 2,431 | $6K | |
| 87070 | <1% | 1,870 | $6K | |
| 82248 | <1% | 2,816 | $6K | |
| 82247 | <1% | 2,401 | $5K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 29 | $5K |
| 80202 | <1% | 726 | $5K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 102 | $5K |
| 82550 | <1% | 1,718 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 294 | $4K |
| 82077 | <1% | 387 | $4K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 293 | $4K |
| 82746 | <1% | 694 | $4K | |
| 86480 | <1% | 150 | $4K | |
| 83540 | <1% | 1,185 | $4K | |
| 86803 | <1% | 513 | $4K | |
| 83970 | <1% | 232 | $4K | |
| 87340 | <1% | 617 | $4K | |
| 84030 | <1% | 1,047 | $3K | |
| 84145 | <1% | 185 | $2K | |
| 82043 | <1% | 1,273 | $2K | |
| 84703 | <1% | 690 | $2K | |
| 81003 | <1% | 2,253 | $2K | |
| 82140 | <1% | 503 | $2K | |
| 85652 | <1% | 1,694 | $2K | |
| 87205 | <1% | 1,216 | $2K | |
| 84132 | <1% | 998 | $2K | |
| 84550 | <1% | 1,062 | $2K | |
| 86880 | <1% | 644 | $2K | |
| 87075 | <1% | 302 | $2K | |
| 87081 | <1% | 675 | $2K | |
| 82810 | <1% | 397 | $2K | |
| 83013 | <1% | 82 | $2K | |
| 84403 | <1% | 142 | $2K | |
| 87210 | <1% | 722 | $2K | |
| 86780 | <1% | 211 | $2K | |
| 84156 | <1% | 1,279 | $1K | |
| 87449 | <1% | 177 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 172 | $1K |
| 87420 | <1% | 162 | $1K | |
| 82565 | <1% | 559 | $1K | |
| 86762 | <1% | 257 | $1K | |
| 84153 | <1% | 200 | $1K | |
| 86592 | <1% | 639 | $1K | |
| 86787 | <1% | 181 | $1K | |
| 83001 | <1% | 127 | $1K | |
| 85007 | <1% | 618 | $1K | |
| 80074 | <1% | 54 | $1K | |
| 85018 | <1% | 853 | $1K | |
| 85520 | <1% | 240 | $1K | |
| 82951 | <1% | 162 | $1K | |
| 83655 | <1% | 171 | $978.50 | |
| 87806 | <1% | 99 | $973.17 | |
| 83615 | <1% | 354 | $931.23 | |
| 84270 | <1% | 116 | $905.98 | |
| 86920 | <1% | 242 | $876.90 | |
| 81513 | <1% | 19 | $833.20 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 32 | $779.28 |
| 83021 | <1% | 125 | $774.68 | |
| 85014 | <1% | 597 | $734.54 | |
| 82950 | <1% | 314 | $720.01 | |
| 86765 | <1% | 153 | $684.71 | |
| 86039 | <1% | 132 | $683.78 | |
| 87581 | <1% | 29 | $664.10 | |
| 87486 | <1% | 29 | $664.10 | |
| 85045 | <1% | 538 | $657.20 | |
| 87493 | <1% | 30 | $645.77 | |
| 84146 | <1% | 86 | $566.72 | |
| 86769 | <1% | 21 | $526.72 | |
| 84144 | <1% | 72 | $505.05 | |
| 86706 | <1% | 98 | $504.97 | |
| 80076 | <1% | 127 | $469.32 | |
| 86593 | <1% | 208 | $410.00 | |
| 89051 | <1% | 124 | $389.51 | |
| 83002 | <1% | 49 | $307.80 | |
| 82533 | <1% | 42 | $284.38 | |
| 84300 | <1% | 127 | $277.72 | |
| 83516 | <1% | 27 | $243.04 | |
| 82150 | <1% | 75 | $237.10 | |
| 84481 | <1% | 42 | $236.37 | |
| 87522 | Neg quan hep c or qual rna | <1% | 12 | $224.91 |
| 88304 | <1% | 12 | $210.05 | |
| 83520 | <1% | 29 | $202.88 | |
| 86308 | <1% | 83 | $200.30 | |
| 86735 | <1% | 30 | $190.50 | |
| 80164 | <1% | 42 | $187.33 | |
| 86431 | <1% | 62 | $169.03 | |
| 82670 | <1% | 14 | $122.25 | |
| 82330 | <1% | 16 | $113.56 | |
| 86376 | <1% | 16 | $81.60 | |
| 87899 | <1% | 17 | $79.04 | |
| 84157 | <1% | 15 | $18.00 | |
| 84155 | <1% | 12 | $16.20 | |
| 87077 | 0% | 46 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.